Oranix Solution (oral rinse) (Benzydamine HCl 22,5 mg/15 ml; Chlorhexidine gluconate 18,0 mg/15 ml)

Oranix Solution (oral rinse) (Benzydamine HCl 22,5 mg/15 ml; Chlorhexidine gluconate 18,0 mg/15 ml)

Company name & Address:  

registration number

 

Batch number(s)

 

Expiry date

 

Pack size

 

First distributed

 

Re-call Classification

 

Re-call Date

iNova Pharmaceuticals (Pty) Ltd

15E Riley Road, Bedfordview, 2007 South Africa

 

34/16.4/0391

 

126189

 

11/2023

 

200 ml

 

13.12.2021

 

Class III Type C

28 January 2022

 

Reason for recall

This product is being recalled due to a complaint relating to quality defect: The assay of the active pharmaceutical ingredient, chlorhexidine gluconate, is below approved specification and the efficacy of this product cannot be guaranteed, (Assay limit of Chlorhexidine Gluconate ut of specification).

 

Advice to HCPs/Distributors/Public:

Immediate batch tracing, quarantine of stock from all distributors & their clients, immediate notification to recall the batches

 

Reporting side effects

Public and healthcare professionals are encouraged to report any side effects after using a health product or after immunisation by using the Med Safety App. Your report will contribute to our monitoring of these health products.

Download latest version
Version: 1
Date Updated: 28/01/2022
File Type: www
Category: Product Recall
Unit: General ECTD & human medicines, Regulatory Compliance